{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T08:44:32Z","timestamp":1790930672343,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T00:00:00Z","timestamp":1549843200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Med. Toxicol."],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s13181-019-00697-z","type":"journal-article","created":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T15:43:05Z","timestamp":1549899785000},"page":"184-191","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Adverse Effects of Physostigmine"],"prefix":"10.1007","volume":"15","author":[{"given":"Ann M.","family":"Arens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Kearney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,11]]},"reference":[{"issue":"11","key":"697_CR1","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/S0196-0644(80)80232-0","volume":"9","author":"P Pentel","year":"1980","unstructured":"Pentel P, Peterson CD. Asystole complicating physostigmine treatment of tricyclic antidepressant overdose. Ann Emerg Med. 1980;9(11):588\u201390.","journal-title":"Ann Emerg Med"},{"issue":"2","key":"697_CR2","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s13181-014-0452-x","volume":"11","author":"JW Watkins","year":"2015","unstructured":"Watkins JW, Schwarz ES, Arroyo-Plasencia AM, Mullins ME. Toxicology Investigators Consortium i. The use of physostigmine by toxicologists in anticholinergic toxicity. J Med Toxicol. 2015;11(2):179\u201384. https:\/\/doi.org\/10.1007\/s13181-014-0452-x .","journal-title":"J Med Toxicol"},{"issue":"4","key":"697_CR3","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/S0196-0644(00)70057-6","volume":"35","author":"MJ Burns","year":"2000","unstructured":"Burns MJ, Linden CH, Graudins A, Brown RM, Fletcher KE. A comparison of physostigmine and benzodiazepines for the treatment of anticholinergic poisoning. Ann Emerg Med. 2000;35(4):374\u201381.","journal-title":"Ann Emerg Med"},{"issue":"2","key":"697_CR4","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1527-3458.1998.tb00059.x","volume":"4","author":"DJ Triggle","year":"1998","unstructured":"Triggle DJ, Mitchell JM, Filler R. The pharmacology of physostigmine. CNS Drug Reviews. 1998;4(2):87\u2013136. https:\/\/doi.org\/10.1111\/j.1527-3458.1998.tb00059.x .","journal-title":"CNS Drug Reviews"},{"issue":"3","key":"697_CR5","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1542\/peds.52.3.449","volume":"52","author":"BH Rumack","year":"1973","unstructured":"Rumack BH. Anticholinergic poisoning: treatment with physostigmine. Pediatrics. 1973;52(3):449\u201351.","journal-title":"Pediatrics"},{"issue":"10","key":"697_CR6","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1213\/00000539-198310000-00005","volume":"62","author":"E Nilsson","year":"1983","unstructured":"Nilsson E, Meretoja OA, Neuvonen P. Hemodynamic responses to physostigmine in patients with a drug overdose. Anesth Analg. 1983;62(10):885\u20138.","journal-title":"Anesth Analg"},{"issue":"3","key":"697_CR7","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1213\/00000539-197705000-00006","volume":"56","author":"GF Larson","year":"1977","unstructured":"Larson GF, Hurlbert BJ, Wingard DW. Physostigmine reversal of diazepam-induced depression. Anesth Analg. 1977;56(3):348\u201351.","journal-title":"Anesth Analg"},{"issue":"4","key":"697_CR8","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1093\/bja\/54.4.429","volume":"54","author":"M Weinstock","year":"1982","unstructured":"Weinstock M, Davidson JT, Rosin AJ, Schnieden H. Effect of physostigmine on morphine-induced postoperative pain and somnolence. Br J Anaesth. 1982;54(4):429\u201334.","journal-title":"Br J Anaesth"},{"issue":"2","key":"697_CR9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1399-6576.1986.tb02392.x","volume":"30","author":"P Hartvig","year":"1986","unstructured":"Hartvig P, Wiklund L, Lindstrom B. Pharmacokinetics of physostigmine after intravenous, intramuscular and subcutaneous administration in surgical patients. Acta Anaesthesiol Scand. 1986;30(2):177\u201382.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"3","key":"697_CR10","first-page":"219","volume":"40","author":"HJ Schneck","year":"1989","unstructured":"Schneck HJ, Rupreht J. Central anticholinergic syndrome (CAS) in anesthesia and intensive care. Acta Anaesthesiol Belg. 1989;40(3):219\u201328.","journal-title":"Acta Anaesthesiol Belg"},{"issue":"3","key":"697_CR11","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3109\/15563658308990429","volume":"21","author":"J Rupreht","year":"2008","unstructured":"Rupreht J, Dworacek B, Oosthoek H, Dzoljic MR, Valkenburg M. Physostigmine versus naloxone in heroin-overdose. J Toxicol Clin Toxicol. 2008;21(3):387\u201397. https:\/\/doi.org\/10.3109\/15563658308990429 .","journal-title":"J Toxicol Clin Toxicol"},{"issue":"1","key":"697_CR12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1067\/mem.2001.111642","volume":"37","author":"DG Caldicott","year":"2001","unstructured":"Caldicott DG, Kuhn M. Gamma-hydroxybutyrate overdose and physostigmine: teaching new tricks to an old drug? Ann Emerg Med. 2001;37(1):99\u2013102. https:\/\/doi.org\/10.1067\/mem.2001.111642 .","journal-title":"Ann Emerg Med"},{"issue":"3","key":"697_CR13","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/0009-9236(95)90246-5","volume":"58","author":"S Asthana","year":"1995","unstructured":"Asthana S, Greig NH, Hegedus L, Holloway HH, Raffaele KC, Schapiro MB, et al. Clinical pharmacokinetics of physostigmine in patients with Alzheimer\u2019s disease. Clin Pharmacol Ther. 1995;58(3):299\u2013309. https:\/\/doi.org\/10.1016\/0009-9236(95)90246-5 .","journal-title":"Clin Pharmacol Ther"},{"issue":"7560","key":"697_CR14","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0140-6736(68)90425-X","volume":"2","author":"G Cumming","year":"1968","unstructured":"Cumming G, Harding LK, Prowse K. Treatment and recovery after massive overdose of physostigmine. Lancet. 1968;2(7560):147\u20139.","journal-title":"Lancet"},{"issue":"3","key":"697_CR15","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.neuropharm.2004.05.002","volume":"47","author":"R Salas","year":"2004","unstructured":"Salas R, Cook KD, Bassetto L, De Biasi M. The alpha3 and beta4 nicotinic acetylcholine receptor subunits are necessary for nicotine-induced seizures and hypolocomotion in mice. Neuropharmacology. 2004;47(3):401\u20137. https:\/\/doi.org\/10.1016\/j.neuropharm.2004.05.002 .","journal-title":"Neuropharmacology"},{"issue":"2","key":"697_CR16","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.yebeh.2012.07.004","volume":"25","author":"M Gholami","year":"2012","unstructured":"Gholami M, Saboory E, Zare S, Roshan-Milani S, Hajizadeh-Moghaddam A. The effect of dorsal hippocampal administration of nicotinic and muscarinic cholinergic ligands on pentylenetetrazol-induced generalized seizures in rats. Epilepsy Behav. 2012;25(2):244\u20139. https:\/\/doi.org\/10.1016\/j.yebeh.2012.07.004 .","journal-title":"Epilepsy Behav"},{"issue":"5","key":"697_CR17","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1111\/epi.12967","volume":"56","author":"M Trivisano","year":"2015","unstructured":"Trivisano M, Terracciano A, Milano T, Cappelletti S, Pietrafusa N, Bertini ES, et al. Mutation of CHRNA2 in a family with benign familial infantile seizures: potential role of nicotinic acetylcholine receptor in various phenotypes of epilepsy. Epilepsia. 2015;56(5):e53\u20137. https:\/\/doi.org\/10.1111\/epi.12967 .","journal-title":"Epilepsia"},{"issue":"9","key":"697_CR18","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1176\/ajp.133.9.1018","volume":"133","author":"PC Holinger","year":"1976","unstructured":"Holinger PC, Klawans HL. Reversal of tricyclic-overdosage-induced central anticholinergic syndrome by physostigmine. Am J Psychiatry. 1976;133(9):1018\u201323. https:\/\/doi.org\/10.1176\/ajp.133.9.1018 .","journal-title":"Am J Psychiatry"},{"issue":"10","key":"697_CR19","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1001\/jama.1974.03240100023020","volume":"230","author":"JS Burks","year":"1974","unstructured":"Burks JS, Walker JE, Rumack BH, Ott JE. Tricyclic antidepressant poisoning. Reversal of coma, choreoathetosis, and myoclonus by physostigmine. JAMA. 1974;230(10):1405\u20137.","journal-title":"JAMA"},{"issue":"2","key":"697_CR20","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0736-4679(03)00169-0","volume":"25","author":"JR Suchard","year":"2003","unstructured":"Suchard JR. Assessing physostigmine\u2019s contraindication in cyclic antidepressant ingestions. J Emerg Med. 2003;25(2):185\u201391. https:\/\/doi.org\/10.1016\/s0736-4679(03)00169-0 .","journal-title":"J Emerg Med"},{"issue":"2","key":"697_CR21","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1542\/peds.67.2.280","volume":"67","author":"BE Magera","year":"1981","unstructured":"Magera BE, Betlach CJ, Sweatt AP, Derrick CW Jr. Hydroxyzine intoxication in a 13-month-old child. Pediatrics. 1981;67(2):280\u20133.","journal-title":"Pediatrics"},{"issue":"9","key":"697_CR22","doi-asserted-by":"publisher","first-page":"846","DOI":"10.3109\/15563650.2011.624100","volume":"49","author":"F Eyer","year":"2011","unstructured":"Eyer F, Pfab R, Felgenhauer N, Strubel T, Saugel B, Zilker T. Clinical and analytical features of severe suicidal quetiapine overdoses--a retrospective cohort study. Clin Toxicol (Phila). 2011;49(9):846\u201353. https:\/\/doi.org\/10.3109\/15563650.2011.624100 .","journal-title":"Clin Toxicol (Phila)."},{"issue":"9","key":"697_CR23","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1001\/jama.1975.03240210021012","volume":"231","author":"RW Newton","year":"1975","unstructured":"Newton RW. Physostigmine salicylate in the treatment of tricyclic antidepressant overdosage. JAMA. 1975;231(9):941\u20133.","journal-title":"JAMA"},{"issue":"3","key":"697_CR24","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1177\/0310057X7900700316","volume":"7","author":"GO Stewart","year":"1979","unstructured":"Stewart GO. Convulsions after physostigmine. Anaesth Intensive Care. 1979;7(3):283.","journal-title":"Anaesth Intensive Care"},{"issue":"14","key":"697_CR25","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1001\/jama.1976.03260400040028","volume":"235","author":"J Tobis","year":"1976","unstructured":"Tobis J, Das BN. Cardiac complications in amitriptyline poisoning. Successful treatment with physostigmine. JAMA. 1976;235(14):1474\u20136.","journal-title":"JAMA"},{"issue":"1","key":"697_CR26","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1067\/mem.2003.232","volume":"42","author":"AB Schneir","year":"2003","unstructured":"Schneir AB, Offerman SR, Ly BT, Davis JM, Baldwin RT, Williams SR, et al. Complications of diagnostic physostigmine administration to emergency department patients. Ann Emerg Med. 2003;42(1):14\u20139. https:\/\/doi.org\/10.1067\/mem.2003.232 .","journal-title":"Ann Emerg Med"},{"issue":"2","key":"697_CR27","first-page":"5","volume":"12","author":"JJSK Rasimas","year":"2014","unstructured":"Rasimas JJSK, Donovan JW. Revival of an antidote: bedside experience with physostigmine. J Am Assoc Emerg Psychiatry. 2014;12(2):5\u201324.","journal-title":"J Am Assoc Emerg Psychiatry"},{"issue":"10","key":"697_CR28","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1213\/00000539-198610000-00013","volume":"65","author":"AA Artru","year":"1986","unstructured":"Artru AA, Hui GS. Physostigmine reversal of general anesthesia for intraoperative neurological testing: associated EEG changes. Anesth Analg. 1986;65(10):1059\u201362.","journal-title":"Anesth Analg"},{"issue":"3","key":"697_CR29","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/00000542-197603000-00017","volume":"44","author":"AV Bidwai","year":"1976","unstructured":"Bidwai AV, Cornelius LR, Stanley TH. Reversal of innovar-induced postanesthetic somnolence and disorientation with physostigmine. Anesthesiology. 1976;44(3):249\u201352.","journal-title":"Anesthesiology"},{"issue":"6","key":"697_CR30","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1213\/00000539-197311000-00013","volume":"52","author":"RE Holzgrafe","year":"1973","unstructured":"Holzgrafe RE, Vondrell JJ, Mintz SM. Reversal of postoperative reactions to scopolamine with physostigmine. Anesth Analg. 1973;52(6):921\u20135.","journal-title":"Anesth Analg"},{"issue":"1","key":"697_CR31","doi-asserted-by":"publisher","first-page":"53","DOI":"10.7326\/0003-4819-91-1-53","volume":"91","author":"GR Avant","year":"1979","unstructured":"Avant GR, Speeg KV Jr, Freemon FR, Schenker S, Berman ML. Physostigmine reversal of diazepam-induced hypnosis. A study in human volunteers. Ann Intern Med. 1979;91(1):53\u20135.","journal-title":"Ann Intern Med"},{"issue":"10","key":"697_CR32","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1093\/bja\/46.10.793","volume":"46","author":"JS Gillick","year":"1974","unstructured":"Gillick JS. Atropine toxicity in a neonate. Br J Anaesth. 1974;46(10):793\u20134.","journal-title":"Br J Anaesth"},{"issue":"4","key":"697_CR33","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1177\/0310057X7600400419","volume":"4","author":"RS Henderson","year":"1976","unstructured":"Henderson RS, Holmes CM. Reversal of the anaesthetic action of sodium gamma-hydroxybutyrate. Anaesth Intensive Care. 1976;4(4):351\u20134.","journal-title":"Anaesth Intensive Care"},{"issue":"3","key":"697_CR34","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1097\/00006565-199806000-00015","volume":"14","author":"M Shannon","year":"1998","unstructured":"Shannon M. Toxicology reviews: physostigmine. Pediatr Emerg Care. 1998;14(3):224\u20136.","journal-title":"Pediatr Emerg Care"},{"issue":"4","key":"697_CR35","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/S0196-0644(81)80174-6","volume":"10","author":"K Kulig","year":"1981","unstructured":"Kulig K, Rumack BH. Physostigmine and asystole. Ann Emerg Med. 1981;10(4):228\u20130.","journal-title":"Ann Emerg Med"},{"issue":"4","key":"697_CR36","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/S0749-0704(05)70371-7","volume":"13","author":"PF Kolecki","year":"1997","unstructured":"Kolecki PF, Curry SC. Poisoning by sodium channel blocking agents. Crit Care Clin. 1997;13(4):829\u201348.","journal-title":"Crit Care Clin"},{"issue":"3","key":"697_CR37","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1080\/15563650601072159","volume":"45","author":"DL Zvosec","year":"2007","unstructured":"Zvosec DL, Smith SW, Litonjua R, Westfal RE. Physostigmine for gamma-hydroxybutyrate coma: inefficacy, adverse events, and review. Clin Toxicol (Phila). 2007;45(3):261\u20135. https:\/\/doi.org\/10.1080\/15563650601072159 .","journal-title":"Clin Toxicol (Phila)"},{"issue":"4","key":"697_CR38","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/BF03007867","volume":"30","author":"AH Maister","year":"1983","unstructured":"Maister AH. Atrial fibrillation following physostigmine. Can Anaesth Soc J. 1983;30(4):419\u201321.","journal-title":"Can Anaesth Soc J"},{"issue":"6","key":"697_CR39","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/0736-4679(91)90217-4","volume":"9","author":"LK Danze","year":"1991","unstructured":"Danze LK, Langdorf MI. Reversal of orphenadrine-induced ventricular tachycardia with physostigmine. J Emerg Med. 1991;9(6):453\u20137.","journal-title":"J Emerg Med"},{"issue":"11","key":"697_CR40","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1097\/00003246-199711000-00036","volume":"25","author":"W Schmidt","year":"1997","unstructured":"Schmidt W, Lang K. Life-threatening dysrhythmias in severe thioridazine poisoning treated with physostigmine and transient atrial pacing. Crit Care Med. 1997;25(11):1925\u201330.","journal-title":"Crit Care Med"},{"issue":"12","key":"697_CR41","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1177\/000992287601501208","volume":"15","author":"SP Wright","year":"1976","unstructured":"Wright SP. Usefulness of physostigmine in imipramine poisoning. A dramatic response in a child resistant to other therapy. Clin Pediatr (Phila). 1976;15(12):1123\u20138. https:\/\/doi.org\/10.1177\/000992287601501208 .","journal-title":"Clin Pediatr (Phila)"},{"issue":"2","key":"697_CR42","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1213\/00000539-197103000-00013","volume":"50","author":"LT Greene","year":"1971","unstructured":"Greene LT. Physostigmine treatment of anticholinergic-drug depression in postoperative patients. Anesth Analg. 1971;50(2):222\u20136.","journal-title":"Anesth Analg"},{"issue":"1","key":"697_CR43","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1177\/0310057X8000800116","volume":"8","author":"J Boon","year":"1980","unstructured":"Boon J, Prideaux PR. Cardiac arrest following physostigmine. Anaesth Intensive Care. 1980;8(1):92\u20133.","journal-title":"Anaesth Intensive Care"},{"issue":"8","key":"697_CR44","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1001\/jama.1979.03290340044026","volume":"241","author":"SR Mogelnicki","year":"1979","unstructured":"Mogelnicki SR, Waller JL, Finlayson DC. Physostigmine reversal of cimetidine--induced mental confusion. JAMA. 1979;241(8):826\u20137.","journal-title":"JAMA"},{"issue":"4","key":"697_CR45","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/00006565-198512000-00008","volume":"1","author":"R Ryan 3rd","year":"1985","unstructured":"Ryan R 3rd, Wians FH Jr, Stigelman WH Jr, Clark H, McCurdy F. Imipramine poisoning in a child: lack of efficacy of resin hemoperfusion. Pediatr Emerg Care. 1985;1(4):201\u20134.","journal-title":"Pediatr Emerg Care"},{"issue":"9","key":"697_CR46","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1176\/ajp.135.9.1114b","volume":"135","author":"MV Ordiway","year":"1978","unstructured":"Ordiway MV. Treating tricyclic overdose with physostigmine. Am J Psychiatry. 1978;135(9):1114.","journal-title":"Am J Psychiatry"},{"issue":"13","key":"697_CR47","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1001\/jama.1977.03270400015002","volume":"237","author":"JT Bigger Jr","year":"1977","unstructured":"Bigger JT Jr, Kantor SJ, Glassman AH, Perel JM. Is physostigmine effective for cardiac toxicity of tricyclic antidepressant drugs. JAMA. 1977;237(13):1311.","journal-title":"JAMA"},{"issue":"5","key":"697_CR48","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1136\/hrt.77.5.461","volume":"77","author":"AM Saadeh","year":"1997","unstructured":"Saadeh AM, Farsakh NA, Al-Ali MK. Cardiac manifestations of acute carbamate and organophosphate poisoning. Heart. 1997;77(5):461\u20134.","journal-title":"Heart"},{"key":"697_CR49","doi-asserted-by":"publisher","unstructured":"Linz D, Elliott AD, Hohl M, Malik V, Schotten U, Dobrev D, et al. Role of autonomic nervous system in atrial fibrillation. Int J Cardiol. 2018. https:\/\/doi.org\/10.1016\/j.ijcard.2018.11.091 .","DOI":"10.1016\/j.ijcard.2018.11.091"},{"issue":"6","key":"697_CR50","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/j.1365-2044.1978.tb08396.x","volume":"33","author":"AE May","year":"1978","unstructured":"May AE, Machin JR, Wyatt R. Physostigmine in open-heart surgery. Reversal of hyoscine supplementation of morphine-oxygen-air-relaxant anaesthesia. Anaesthesia. 1978;33(6):547\u201350.","journal-title":"Anaesthesia"}],"updated-by":[{"DOI":"10.1007\/s13181-019-00730-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T00:00:00Z","timestamp":1565740800000}}],"container-title":["Journal of Medical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13181-019-00697-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-019-00697-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-019-00697-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T18:48:18Z","timestamp":1662922098000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13181-019-00697-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,11]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["697"],"URL":"https:\/\/doi.org\/10.1007\/s13181-019-00697-z","relation":{},"ISSN":["1556-9039","1937-6995"],"issn-type":[{"value":"1556-9039","type":"print"},{"value":"1937-6995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,11]]},"assertion":[{"value":"27 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2019","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In \u201cAdverse Effects of Physostigmine\u201d by Arens et al in the July 2019 issue of JMT, reference #27 contains an error.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}]}}